Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Clin Nutr ; 43(7): 1696-1705, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38823267

ABSTRACT

Parenteral nutrition (PN) is recognized as a complex high-risk therapy. Its practice is highly variable and frequently suboptimal in pediatric patients. Optimizing care requires evidence, consensus-based guidelines, audits of practice, and standardized strategies. Several pediatric scientific organizations, expert panels, and authorities have recently recommended that standardized PN should generally be used over individualized PN in the majority of pediatric patients including very low birth weight premature infants. In addition, PN admixtures produced and validated by a suitably qualified institution are recommended over locally produced PN. Licensed multi chamber bags are standardized PN bags that comply with Good Manufacturing Practice and high-quality standards for the finished product in the frame of their full manufacturing license. The purpose of this article is to review the practical aspects of PN and the evidence for using such multi-chamber bags in pediatric patients. It highlights the safety characteristics and the limitations of the different PN practices and provides some guidance for ensuring safe and efficient therapy in pediatric patients.

2.
JAMA Pediatr ; 176(5): 452-460, 2022 05 01.
Article in English | MEDLINE | ID: mdl-35226099

ABSTRACT

IMPORTANCE: Feeding intolerance is a common condition among preterm infants owing to immaturity of the gastrointestinal tract. Enteral insulin appears to promote intestinal maturation. The insulin concentration in human milk declines rapidly post partum and insulin is absent in formula; therefore, recombinant human (rh) insulin for enteral administration as a supplement to human milk and formula may reduce feeding intolerance in preterm infants. OBJECTIVE: To assess the efficacy and safety of 2 different dosages of rh insulin as a supplement to both human milk and preterm formula. DESIGN, SETTING, AND PARTICIPANTS: The FIT-04 multicenter, double-blind, placebo-controlled randomized clinical trial was conducted at 46 neonatal intensive care units throughout Europe, Israel, and the US. Preterm infants with a gestational age (GA) of 26 to 32 weeks and a birth weight of 500 g or more were enrolled between October 9, 2016, and April 25, 2018. Data were analyzed in January 2020. INTERVENTIONS: Preterm infants were randomly assigned to receive low-dose rh insulin (400-µIU/mL milk), high-dose rh insulin (2000-µIU/mL milk), or placebo for 28 days. MAIN OUTCOMES AND MEASURES: The primary outcome was time to achieve full enteral feeding (FEF) defined as an enteral intake of 150 mL/kg per day or more for 3 consecutive days. RESULTS: The final intention-to-treat analysis included 303 preterm infants (low-dose group: median [IQR] GA, 29.1 [28.1-30.4] weeks; 65 boys [59%]; median [IQR] birth weight, 1200 [976-1425] g; high-dose group: median [IQR] GA, 29.0 [27.7-30.5] weeks; 52 boys [55%]; median [IQR] birth weight, 1250 [1020-1445] g; placebo group: median [IQR] GA, 28.8 [27.6-30.4] weeks; 54 boys [55%]; median [IQR] birth weight, 1208 [1021-1430] g). The data safety monitoring board advised to discontinue the study early based on interim futility analysis (including the first 225 randomized infants), as the conditional power did not reach the prespecified threshold of 35% for both rh-insulin dosages. The study continued while the data safety monitoring board analyzed and discussed the data. In the final intention-to-treat analysis, the median (IQR) time to achieve FEF was significantly reduced in 94 infants receiving low-dose rh insulin (10.0 [7.0-21.8] days; P = .03) and in 82 infants receiving high-dose rh insulin (10.0 [6.0-15.0] days; P = .001) compared with 85 infants receiving placebo (14.0 [8.0-28.0] days). Compared with placebo, the difference in median (95% CI) time to FEF was 4.0 (1.0-8.0) days for the low-dose group and 4.0 (1.0-7.0) days for the high-dose group. Weight gain rates did not differ significantly between groups. Necrotizing enterocolitis (Bell stage 2 or 3) occurred in 7 of 108 infants (6%) in the low-dose group, 4 of 88 infants (5%) in the high-dose group, and 10 of 97 infants (10%) in the placebo group. None of the infants developed serum insulin antibodies. CONCLUSIONS AND RELEVANCE: Results of this randomized clinical trial revealed that enteral administration of 2 different rh-insulin dosages was safe and compared with placebo, significantly reduced time to FEF in preterm infants with a GA of 26 to 32 weeks. These findings support the use of rh insulin as a supplement to human milk and preterm formula. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02510560.


Subject(s)
Enterocolitis, Necrotizing , Infant, Premature , Birth Weight , Enteral Nutrition/methods , Female , Humans , Infant , Infant, Newborn , Insulin , Male , Milk, Human
4.
Nutrients ; 12(9)2020 Aug 20.
Article in English | MEDLINE | ID: mdl-32825528

ABSTRACT

The safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on clinical outcomes, healthcare resources, and hospital budgets across seven European countries. A ten-percentage-point 3CB use-increase model was developed for Belgium, France, Germany, Italy, Portugal, Spain, and the UK. The cost-consequence analysis estimated the impact on compounding error harm and bloodstream infection (BSI) rates, staff time, and annual hospital budget. Of 265,000 (52%) preterm neonates, 133,000 (52%) were estimated to require PN. Baseline compounding methods were estimated as 43% pharmacy manual, 16% pharmacy automated, 22% ward, 9% outsourced, 3% industry provided non-3CBs, and 7% 3CBs. A modeled increased 3CB use would change these values to 39%, 15%, 18%, 9%, 3%, and 17%, respectively. Modeled consequences included -11.6% for harm due to compounding errors and -2.7% for BSIs. Labor time saved would equate to 41 specialized nurses, 29 senior pharmacists, 26 pharmacy assistants, and 22 senior pediatricians working full time. Budget impact would be a €8,960,601 (3.4%) fall from €260,329,814 to €251,369,212. Even a small increase in the use of 3CBs in preterm neonates could substantially improve neonatal clinical outcomes, and provide notable resource and cost savings to hospitals.


Subject(s)
Costs and Cost Analysis/economics , Health Resources/economics , Health Resources/statistics & numerical data , Infant, Premature , Medical Staff, Hospital/economics , Parenteral Nutrition/economics , Parenteral Nutrition/methods , Patient Acceptance of Health Care/statistics & numerical data , Budgets , Cost Savings , Drug Compounding/economics , Drug Compounding/statistics & numerical data , Economics, Hospital/statistics & numerical data , Europe , Female , Humans , Infant, Newborn , Male , Medical Errors/economics , Medical Errors/statistics & numerical data , Parenteral Nutrition/statistics & numerical data , Safety
5.
J Perinatol ; 40(5): 704-714, 2020 05.
Article in English | MEDLINE | ID: mdl-32214217

ABSTRACT

Preterm infants are increasingly diagnosed as having "extrauterine growth restriction" (EUGR) or "postnatal growth failure" (PGF). Usually EUGR/PGF is diagnosed when weight is <10th percentile at either discharge or 36-40 weeks postmenstrual age. The reasons why the phrases EUGR/PGF are unhelpful include, they: (i) are not predictive of adverse outcome; (ii) are based only on weight without any consideration of head or length growth, proportionality, body composition, or genetic potential; (iii) ignore normal postnatal weight loss; (iv) are usually assessed prior to growth slowing of the reference fetus, around 36-40 weeks, and (v) are usually based on an arbitrary statistical growth percentile cut-off. Focus on EUGR/PGF prevalence may benefit with better attention to nutrition but may also harm with nutrition delivery above infants' actual needs. In this paper, we highlight challenges associated with such arbitrary cut-offs and opportunities for further refinement of understanding growth and nutritional needs of preterm neonates.


Subject(s)
Fetal Growth Retardation , Infant, Premature , Fetal Growth Retardation/diagnosis , Gestational Age , Humans , Infant , Infant, Newborn , Nutritional Status , Patient Discharge
6.
J Pediatr Gastroenterol Nutr ; 69(6): e151-e157, 2019 12.
Article in English | MEDLINE | ID: mdl-31567786

ABSTRACT

OBJECTIVES: Hypermagnesemia has been reported in preterm neonates treated with commercial pediatric triple-chamber bag (3CB) parenteral nutrition (PN). This postmarketing study was requested by the European Medicines Agency to assess the safety of a 3CB PN product in full-term neonates and children up to 24 months of age. METHODS: This prospective, multicenter, observational study enrolled hospitalized, full-term, newborn infants and children up to 24 months of age receiving >70% of nutrition as PN and requiring ≥50% of nutrition as PN for ≥5 days. All patients received 3CB PN during the study for ≤15 days. The primary outcome was serum magnesium, summarized by age group (0-1, >1-12, and >12-24 months). Secondary outcomes were nutritional intake and adverse events (AEs), including clinically significant abnormal laboratory results and vital signs. RESULTS: A total of 102 eligible patients were included. Median (interquartile range) parenteral magnesium intake was 0.23 (0.18-0.30) mmol ·â€Škg ·â€Šday. Mean serum magnesium showed no consistent changes during treatment in any age group. One moderate and 3 mild AEs of hypermagnesemia were reported in 4 patients (3.9%), all ages 0 to 1 month. Other AEs in >2 patients were hypertriglyceridemia (6.9%), laryngitis (3.9%), hyperkalemia, hypokalemia, hyponatremia, hypophosphatemia, and neonatal hypotension (each 2.9%). Other serum electrolytes were stable, and revealed no safety concerns. CONCLUSIONS: Mean serum magnesium levels were not affected by 3CB PN in full-term neonates and children up to 24 months of age. The risk of hypermagnesemia AEs was low when providing median parenteral magnesium of 0.2 to 0.3 mmol ·â€Škg ·â€Šday in this population.


Subject(s)
Magnesium/blood , Parenteral Nutrition Solutions/administration & dosage , Parenteral Nutrition/methods , Child, Preschool , Energy Intake , Female , Humans , Infant , Infant, Newborn , Male , Parenteral Nutrition/adverse effects , Parenteral Nutrition Solutions/adverse effects , Prospective Studies
7.
Nutrients ; 11(4)2019 Apr 03.
Article in English | MEDLINE | ID: mdl-30987136

ABSTRACT

The influence of types of human milk (HM)-raw own mother's milk (OMM), pasteurized OMM, and donor milk (DM)-was evaluated for growth in premature infants fed exclusively HM with controlled nutritional intakes using daily individualized HM fortification (IHMF). Growth and nutritional intakes were prospectively collected in preterm infants (<32 weeks) fed IHMF and compared in infants fed predominantly (≥75%) OMM and DM. The influence of HM types (raw OMM, pasteurized OMM, and DM) on growth were also evaluated in the whole population. One-hundred and one preterm infants (birth weight 970 ± 255 g, gestational age 27.8 ± 1.9 weeks) were included. Energy (143 ± 8 vs. 141 ± 6 kcal/kg/day; p = 0.15) and protein intakes (4.17 ± 0.15 vs. 4.15 ± 0.14 g/kg/day; p = 0.51) were similar in both groups. Infants receiving predominantly OMM (n = 37), gained significantly more weight (19.8 ± 2.0 vs. 18.2 ± 2.2 g/kg/day; p = 0.002) and length (1.17 ± 0.26 vs. 0.99 ± 0.36 cm/week; p = 0.020) than those fed predominantly DM (n = 33). Stepwise multivariate analysis (n = 101) suggests that raw OMM was the major determinant of growth, contributing 22.7% of weight gain. Length gain was also related to OMM (raw + pasteurized) intakes, explaining 4.0% of length gain. In conclusion, at daily controlled similar protein and energy intakes, OMM had significant beneficial effects on weight and length versus DM in VLBW infants. This difference could be partially explained by the use of raw OMM.


Subject(s)
Breast Feeding , Breast Milk Expression , Food, Fortified , Infant Nutritional Physiological Phenomena , Infant, Premature/growth & development , Infant, Very Low Birth Weight/growth & development , Milk, Human , Nutritive Value , Weight Gain , Birth Weight , Child Development , Energy Intake , Female , Gestational Age , Humans , Infant , Infant, Newborn , Male , Milk Proteins/administration & dosage , Nutritional Status , Pasteurization , Pregnancy , Prospective Studies , Time Factors
8.
Pediatr Res ; 85(5): 650-654, 2019 04.
Article in English | MEDLINE | ID: mdl-30705399

ABSTRACT

BACKGROUND: We examined preterm infants' weight gain velocity (WGV) to determine how much calculation methods influences actual WGV during the first 28 days of life. METHODS: WGV methods (Average 2-point, Exponential 2-point, Early 1-point, and Daily) were calculated weekly and for various start times (birth, nadir, regain, day 3 and day 7) to 28 days of age for 103 preterm < 1500 gram infants, with daily weights. RESULTS: Range of WGV estimates decreased 10-22 g/kg/day to 15.5-15.8 g/kg/day when the Early 1-point method and the postnatal weight loss phase were excluded. WGV were lower when the postnatal weight loss was included and higher using the early method. WGV calculations beginning at day 7 did not differ from calculations beginning at the nadir. CONCLUSIONS: Variations in WGV calculations were large enough to create difficulties for comparing results between studies and translating research to practice. We recommend that the postnatal weight loss phase be excluded from WGV calculations and clinical studies report weight nadir and weights at day 7 and 28 to allow adequate comparison and translation of findings in clinical practice. The Average2pt method may be easier to calculate at bedside, so we recommend it be used in clinical settings and research summaries. The Early1pt method should not be used to summarize WGV for research.


Subject(s)
Anthropometry/methods , Body Weight , Infant, Premature/physiology , Weight Gain , Data Collection , Female , Humans , Infant, Newborn , Infant, Newborn, Diseases , Male , Reference Values , Reproducibility of Results , Weight Loss
9.
Arch Dis Child Fetal Neonatal Ed ; 104(2): F218-F219, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29997166

ABSTRACT

Calculation of weight gain velocity is used to guide nutrition and fluid management practices in neonatal intensive care units. Calculations over short time periods may be more responsive to management changes, but less precise. Weight gain velocity calculated over 5 to 7+ days have lower variability and less noise than shorter periods.


Subject(s)
Infant, Premature , Intensive Care Units, Neonatal , Monitoring, Physiologic/methods , Weight Gain , Humans , Infant, Newborn , Time Factors
11.
J Pediatr ; 196: 77-83, 2018 05.
Article in English | MEDLINE | ID: mdl-29246464

ABSTRACT

OBJECTIVE: To examine how well growth velocity recommendations for preterm infants fit with current growth references: Fenton 2013, Olsen 2010, INTERGROWTH 2015, and the World Health Organization Growth Standard 2006. STUDY DESIGN: The Average (2-point), Exponential (2-point), Early (1-point) method weight-gains were calculated for 1,4,8,12, and 16-week time-periods. Growth references' weekly velocities (g/kg/d, gram/day and cm/week) were illustrated graphically with frequently-quoted 15 g/kg/d, 10-30 grams/day and 1 cm/week rates superimposed. The 15 g/kg/d and 1 cm/week growth velocity rates were calculated from 24-50 weeks, superimposed on the Fenton and Olsen preterm growth charts. RESULTS: The Average and Exponential g/kg/d estimates showed close agreement for all ages (range 5.0-18.9 g/kg/d), while the Early method yielded values as high as 41 g/kg/d. All 3 preterm growth references were similar to 15 g/kg/d rate at 34 weeks, but rates were higher prior and lower at older ages. For gram/day, the growth references changed from 10 to 30 grams/day for 24-33 weeks. Head growth rates generally fit the 1 cm/week velocity for 23-30 weeks, and length growth rates fit for 37-40 weeks. The calculated g/kg/d curves deviated from the growth charts, first downward, then steeply crossed the median curves near term. CONCLUSIONS: Human growth is not constant through gestation and early infancy. The frequently-quoted 15 g/kg/d, 10-30 gram/day and 1 cm/week only fit current growth references for limited time periods. Rates of 15-20 g/kg/d (calculated using average or exponential methods) are a reasonable goal for infants 23-36 weeks, but not beyond.


Subject(s)
Growth Charts , Infant, Premature/growth & development , Pediatrics/methods , Pediatrics/standards , Body Height , Body Weight , Female , Gestational Age , Head/physiology , Humans , Infant , Infant, Newborn , Male , Reference Standards , Weight Gain
12.
Pediatrics ; 139(3)2017 Mar.
Article in English | MEDLINE | ID: mdl-28246339

ABSTRACT

CONTEXT: Clinicians assess the growth of preterm infants and compare growth velocity using a variety of methods. OBJECTIVE: We determined the numerical methods used to describe weight, length, and head circumference growth velocity in preterm infants; these methods include grams/kilogram/day (g/kg/d), grams/day (g/d), centimeters/week (cm/week), and change in z scores. DATA SOURCES: A search was conducted in April 2015 of the Medline database by using PubMed for studies that measured growth as a main outcome in preterm neonates between birth and hospital discharge and/or 40 weeks' postmenstrual age. English, French, German, and Spanish articles were included. The systematic review was conducted by using Preferred Reporting Items for Systematic Reviews and Meta-analyses methods. STUDY SELECTION: Of 1543 located studies, 373 (24%) calculated growth velocity. DATA EXTRACTION: We conducted detailed extraction of the 151 studies that reported g/kg/d weight gain velocity. RESULTS: A variety of methods were used. The most frequently used method to calculate weight gain velocity reported in the 1543 studies was g/kg/d (40%), followed by g/d (32%); 29% reported change in z score relative to an intrauterine or growth chart. In the g/kg/d studies, 39% began g/kg/d calculations at birth/admission, 20% at the start of the study, 10% at full feedings, and 7% after birth weight regained. The kilogram denominator was not reported for 62%. Of the studies that did report the denominators, the majority used an average of the start and end weights as the denominator (36%) followed by exponential methods (23%); less frequently used denominators included birth weight (10%) and an early weight that was not birth weight (16%). Nineteen percent (67 of 355 studies) made conclusions regarding extrauterine growth restriction or postnatal growth failure. Temporal trends in head circumference growth and length gain changed from predominantly cm/wk to predominantly z scores. LIMITATIONS AND CONCLUSIONS: The lack of standardization of methods used to calculate preterm infant growth velocity makes comparisons between studies difficult and presents an obstacle to using research results to guide clinical practice.


Subject(s)
Infant, Premature/growth & development , Models, Biological , Body Height , Cephalometry , Humans , Infant , Infant, Low Birth Weight , Infant, Newborn , Weight Gain
13.
J Pediatr Gastroenterol Nutr ; 64(4): 605-609, 2017 04.
Article in English | MEDLINE | ID: mdl-28333827

ABSTRACT

BACKGROUND: Evidence of silicon's importance to health has been gradually accumulating. Nevertheless, there are few studies comparing serum silicon levels in newborns with maternal levels. Likewise, little is known concerning the inter-relation between silicon and other trace elements. OBJECTIVE: The present study evaluated maternal and newborn levels of serum silicon and their relation to those of zinc and copper. METHODS: We measured serum silicon, copper, and zinc in 66 pregnant women, in the umbilical cord of their infants, and in 44 newborns, by atomic absorption spectrophotometry. All the samples were from fasted subjects. RESULTS: Serum silicon level in term newborns (20.6 ±â€Š13.2 µmol/L) was significantly higher than in umbilical cord (8.9 ±â€Š3.5 µmol/L; P < 0.0001). Mean serum silicon level in maternal vein (7.7 ±â€Š3.4 µmol/L) was lower than that in umbilical cord, although differences were not significant. We also found higher levels of zinc (P = 0.008) and lower levels of copper (P < 0.0001) in cord blood compared with maternal blood. Umbilical venous/maternal venous level ratios of zinc, copper, and silicon were 1.5 ±â€Š0.5, 0.2 ±â€Š0.1, and 1.3 ±â€Š0.7, respectively. There was a positive correlation between silicon and zinc levels (r = 0.32), and a negative correlation between copper and zinc levels (r = -0.35). CONCLUSIONS: It seems that there is a positive gradient of silicon from the mother to her fetus. Silicon levels were higher in newborn than in cord blood, and correlated significantly with that of zinc but not copper. Additional investigations are needed to further define the role of silicon and its interaction with other trace elements during the perinatal period.


Subject(s)
Copper/blood , Infant Nutritional Physiological Phenomena , Maternal-Fetal Exchange , Prenatal Nutritional Physiological Phenomena , Silicon/blood , Trace Elements/blood , Zinc/blood , Adult , Biomarkers/blood , Cross-Sectional Studies , Female , Fetal Blood/metabolism , Humans , Infant, Newborn , Male , Pregnancy , Spectrophotometry, Atomic
14.
Semin Fetal Neonatal Med ; 22(1): 23-29, 2017 02.
Article in English | MEDLINE | ID: mdl-27649995

ABSTRACT

Own mother's milk is the first choice in feeding preterm infants and provides multiple short- and long-term benefits. When it is unavailable, donor human milk is recommended as the first alternative. Donor milk undergoes processing (i.e. pasteurization) to reduce bacteriological and viral contaminants but influences its bioactive properties with potentially fewer benefits than raw milk. However, there is no clinical evidence of health benefit of raw compared to pasteurized human milk, and donor milk maintains documented advantages compared to formula. Nutrient content of donor and own mother's milk fails to meet the requirements of preterm infants. Adequate fortification is necessary to provide optimal growth. There are significant challenges in providing donor milk for premature infants; therefore, specific clinical guidelines for human milk banks and donor milk use in the neonatal intensive care unit should be applied and research should focus on innovative solutions to process human milk while preserving its immunological and nutritional components. In addition, milk banks are not the only instrument to collect, process and store donor milk but represent an excellent tool for breastfeeding promotion.


Subject(s)
Infant Nutritional Physiological Phenomena/physiology , Intensive Care Units, Neonatal , Milk Banks , Milk, Human , Humans , Infant, Newborn
15.
Article in English | MEDLINE | ID: mdl-27336633

ABSTRACT

Milk proteins are an essential component of the diet of preterm infants who have high requirements. Hydrolyzed proteins (HPs) have been introduced in infants' formulas (HPFs) to treat gastrointestinal disorders and to prevent allergic diseases. Several studies have evaluated the adequacy of HPs in preterm infants. Protein source significantly influences plasma amino acid concentrations. Protein utilization and efficiency are usually lower with HPFs compared to formulas with intact proteins. When protein intake is similar, a lower weight gain is generally observed with HPFs and a 10% increase in protein content is usually necessary to compensate for this reduction in protein utilization. Mineral absorption may also be reduced and no data exist for trace elements and vitamins. Most HPFs are associated with accelerated gastrointestinal transit time and softer stools but without clear benefit on feeding tolerance. Preterm infants seem to be at similar risk of allergic diseases than term infants, but the preventive effect of HPFs has not been sufficiently explored in preterm infants. Most modern HPFs designed for preterm infants are well tolerated and have adapted their nutrient content to improve nutrient absorption and retention. However, their benefits and safety have not been demonstrated and, therefore, further high-quality studies are needed.


Subject(s)
Infant Formula/chemistry , Infant, Premature/growth & development , Milk Proteins/chemistry , Milk, Human/chemistry , Protein Hydrolysates/chemistry , Child Development , Child, Preschool , Food Hypersensitivity/prevention & control , Gastrointestinal Tract/metabolism , Humans , Infant , Milk Proteins/administration & dosage , Nutritive Value , Protein Hydrolysates/administration & dosage , Randomized Controlled Trials as Topic , Trace Elements/administration & dosage , Trace Elements/analysis , Vitamins/administration & dosage , Vitamins/analysis
16.
J Pediatr Gastroenterol Nutr ; 61(4): 491-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25988555

ABSTRACT

OBJECTIVES: The aim of the present study was to evaluate electrolyte and mineral homeostasis in very-low-birth-weight (VLBW) infants who received high protein and energy intakes with a unique standardized parenteral nutrition solution containing electrolytes and minerals from birth onward. METHODS: Prospective cohort study in 102 infants with birth weight <1250 g. The evolution of plasma biochemical parameters was described during the first 2 weeks of life. RESULTS: During the first 3 days of life, mean parenteral intakes were 51 ±â€Š8 kcal · kg · day with 2.7 ±â€Š0.4 g · kg · day of protein, 1.1 ±â€Š0.2 mmol · kg · day of sodium and potassium, and 1.3 ±â€Š0.2 mmol · kg · day of calcium and phosphorus. Afterwards, most nutritional intakes (parenteral and enteral) met growth requirements. No infant developed a hyperkalemia >7 mmol/L, and a hypernatremia >150 mmol/L occurred only in 15.7% of the infants. In contrast, hyponatremia <130 mmol/L and hypokalemia <3 mmol/L occurred in 30.4% and 8.8% of the infants, respectively. The initial neonatal metabolic acidosis rapidly resolved in most infants and only 2.0% developed a base deficit >10 mmol/L after day 3 of life. Early hypocalcemia <1.8 mmol/L occurred in 13.7% of the infants. In contrast, hypophosphatemia <1.6 mmol/L occurred in 37.3% and hypercalcemia >2.8 mmol/L occurred in 12.7% of the infants. CONCLUSIONS: Increasing early protein and energy intakes in VLBW infants in the first week of life improves electrolyte homeostasis. It also increases the phosphorus requirements with a calcium-to-phosphorus ratio ≤1.0 (mmol/mmol) and the potassium and sodium requirements to avoid the development of a refeeding-like syndrome. These data suggest that the parenteral nutrition guidelines for VLBW infants for the first week of life need to be revised.


Subject(s)
Calcium/therapeutic use , Infant Nutritional Physiological Phenomena , Parenteral Nutrition/adverse effects , Phosphorus/therapeutic use , Potassium/therapeutic use , Sodium/therapeutic use , Water-Electrolyte Imbalance/prevention & control , Acidosis/etiology , Acidosis/prevention & control , Acidosis/therapy , Belgium , Calcium/administration & dosage , Cohort Studies , Combined Modality Therapy , Dietary Proteins/administration & dosage , Energy Intake , Enteral Nutrition , Hospitals, University , Humans , Infant, Newborn , Infant, Very Low Birth Weight , Intensive Care Units, Neonatal , Nutritional Requirements , Phosphorus/administration & dosage , Potassium/administration & dosage , Premature Birth/diet therapy , Premature Birth/physiopathology , Premature Birth/therapy , Prospective Studies , Sodium/administration & dosage , Water-Electrolyte Imbalance/etiology
18.
Am J Clin Nutr ; 100(1): 98-104, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24808483

ABSTRACT

BACKGROUND: Preterm infants have a higher fat mass (FM) percentage and a lower fat-free mass (FFM) than do term infants at the time of hospital discharge. OBJECTIVE: We determined perinatal and nutritional factors that affect the body composition of preterm infants at discharge. DESIGN: A total of 141 preterm infants born at <35 wk of gestation and admitted to Nantes University Hospital Neonatology Unit over a period of 2 y were enrolled. Nutritional intake and growth were monitored during hospitalization. Body composition was assessed by using air-displacement plethysmography at discharge. FFM was compared with reference data in term infants according to sex and gestational age. RESULTS: Linear regression produced an excellent model to predict absolute FFM from perinatal characteristics and nutrition (R(2) = 0.82) but not the FM percentage (R(2) = 0.24). Gestational and postnatal ages played an equal role in absolute FFM accretion, as did the initial growth (between birth and day 5) and growth between day 5 and discharge. Antenatal corticosteroid treatment slightly reduced FFM accretion. As concerns nutritional intake, a higher protein:energy ratio at days 10 and 21 was significantly associated with decreased risk of an FFM deficit when preterm infants were compared with reference values for term infants. Boys had higher risk of an FFM deficit than did girls. CONCLUSION: The initial growth and quality of nutrition were significantly associated with absolute FFM accretion during a hospital stay in preterm infants. This trial was registered at clinicaltrials.gov as NCT01450436.


Subject(s)
Body Composition , Infant, Premature/growth & development , Patient Discharge , Adipose Tissue/metabolism , Body Weight , Energy Intake , Female , Gestational Age , Humans , Infant , Infant Nutritional Physiological Phenomena , Linear Models , Logistic Models , Male , Multivariate Analysis , Plethysmography , Prospective Studies
19.
World Rev Nutr Diet ; 110: 140-51, 2014.
Article in English | MEDLINE | ID: mdl-24751626

ABSTRACT

Proper mineral and vitamin D nutrition in preterm infants is essential for adequate bone health because preterm infants are at a risk of prematurely developing osteopenia. This chapter focuses on nutritional aspects of the requirements after a brief description of the perinatal physiology of minerals and vitamin D. The rationale for estimation of nutritional mineral requirements of the preterm infant (based upon estimates of the intrauterine skeletal accretion rate of minerals, and upon estimates of the coefficient of intestinal absorption) is first described. Previous expert recommendations are reviewed and compared to the present recommendations. Finally, vitamin D requirements are thoroughly reviewed based upon what is known of the physiology of vitamin D in preterm infants. A suggestion that each extremely preterm infant should be monitored for adequate vitamin D status is made.


Subject(s)
Calcium, Dietary/metabolism , Infant Nutritional Physiological Phenomena , Infant, Premature/growth & development , Magnesium/physiology , Phosphorus, Dietary/metabolism , Vitamin D/physiology , Bone Diseases, Metabolic/prevention & control , Homeostasis , Humans , Infant , Nutritional Requirements , Parenteral Nutrition , Perinatal Care
20.
World Rev Nutr Diet ; 110: 201-14, 2014.
Article in English | MEDLINE | ID: mdl-24751631

ABSTRACT

The perinatal period is critical for human development. The brain of very low birth weight (VLBW, <1,500 g) infants is particularly vulnerable to undernutrition. Enteral nutrition is of major importance for the growth and the development of the gastrointestinal tract, which depends on the amount and composition of feeds. Feeding intolerance and the risk of necrotizing enterocolitis (NEC) are key concerns with enteral nutrition in VLBW infants. Controversies exist on how to feed VLBW infants during the first weeks of life, particularly in extremely low birth weight (ELBW, <1,000 g) infants. Unreasonable concerns lead to iatrogenic malnutrition, gastrointestinal atrophy, and parenteral nutrition-related complications. Many studies in the field of nutrition during the past decade demonstrated that some feeding regimens have significant benefits. There is strong evidence that the use of human milk (HM) reduces the risk of NEC and provides major advantages in VLBW infants. The feeding of fortified HM should be promoted and HM banking should be further developed to allow access to pasteurized donor HM for VLBW infants with an insufficient intake of their own mother's milk. Early enteral feeding should be promoted soon after birth to enhance gastrointestinal maturation, growth and functional development. Continuous- or short-interval intermittent feeding seems to provide better gastrointestinal tolerance and faster achievement of full enteral feeding. Feeding advancements of 20-30 ml/kg/day in VLBW infants ≥1,000 g and of 15-25 ml/kg/day in ELBW infants are reasonable strategies. Any suspicion of feeding intolerance implies short-interval evaluation to decide whether interruption of enteral feeding or its restart after a transient interruption are appropriate. One should always strive for maintaining at least minimal enteral feeding, rather than complete interruption of enteral feeding.


Subject(s)
Enteral Nutrition/methods , Infant, Extremely Low Birth Weight/growth & development , Infant, Very Low Birth Weight/growth & development , Enterocolitis, Necrotizing/prevention & control , Humans , Infant , Infant Formula/chemistry , Infant, Premature/growth & development , Milk, Human/chemistry , Nutritional Requirements , Parenteral Nutrition/methods , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...